Bristol Myers Squibb, Sanofi, Pfizer, Roche, and Yarrow Bioscience all added to their pipelines this week in an end-of-year licensing deal flurry.

Empower Pharmacy, a large GLP-1 compounding pharmacy that’s faced allegations of poor quality drugs and a legal challenge from Eli Lilly, has stopped operations at

The European Commission has unveiled a long-awaited proposal to make Europe a “biotech powerhouse” by speeding up clinical trials, extending intellectual property protection and boosting

The Biosecure Act is slated to become law after the Senate on Wednesday passed a defense bill that includes the measure. It’s a development that

HHS Secretary Robert F. Kennedy Jr. added two conditions to a federal newborn screening list, reviving efforts that had been stalled under the Trump administration